Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

AMA Journal of Ethics
Volume 23, Number 5: E371-433 May 2021
https://journalofethics.ama-assn.org/issue/ending-hiv-epidemic

Ending the HIV Epidemic
A human immunodeficiency virus (HIV) epidemic began in the United States in the 1970s. “Ending the HIV Epidemic: A Plan for America” was launched in October 2019 by the US Department of Health and Human Services, with the goal of stopping the spread of HIV by 2030. Accomplishing this goal demands not only expanding existing programs, but recognizing and responding to clinically, ethically, socially, and culturally relevant features of contemporary patients’ experiences of stigma, oppression, and living with HIV. This issue considers ethical and clinical complexities patients and clinicians encounter in HIV care today.

BMJ Global Health
April 2021 – Volume 6 – Suppl 1
https://gh.bmj.com/content/6/Suppl_1

Migration and Health in Social Context
Editorial
Introduction: migration and health in social context (7 April, 2021)
Emily Mendenhall, Seth M Holmes

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 8 May 2021)

Knowledge and preparedness of healthcare providers towards bioterrorism
Several emergent circumstances require healthcare providers to recognize the unusual and dangerous and pathogenic agents. An in-depth literature review showed that studies about bioterrorism preparedness among…
Authors: Abdullah Nofal, Isamme AlFayyad, Nawfal AlJerian, Jalal Alowais, Meshal AlMarshady, Anas Khan, Humariya Heena, Ayah Sulaiman AlSarheed and Amani Abu-Shaheen
Citation: BMC Health Services Research 2021 21:426
Content type: Research article
Published on: 5 May 2021

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 8 May 2021)

Self-management interventions for adolescents living with HIV: a systematic review
Self-management interventions aim to enable people living with chronic conditions to increase control over their condition in order to achieve optimal health and may be pertinent for young people with chronic …
Authors: Talitha Crowley and Anke Rohwer
Citation: BMC Infectious Diseases 2021 21:431
Content type: Research
Published on: 7 May 2021

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 8 May 2021)

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness in tre…
Authors: Nurullah Okumuş, Neşe Demirtürk, Rıza Aytaç Çetinkaya, Rahmet Güner, İsmail Yaşar Avcı, Semiha Orhan, Petek Konya, Bengü Şaylan, Ayşegül Karalezli, Levent Yamanel, Bircan Kayaaslan, Gülden Yılmaz, Ümit Savaşçı, Fatma Eser and Gürhan Taşkın
Citation: BMC Infectious Diseases 2021 21:411
Content type: Research
Published on: 4 May 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 8 May 2021)

The Socioecological Model as a framework for exploring factors influencing childhood immunization uptake in Lagos state, Nigeria
Nigeria is one of the ten countries globally that account for 62% of under- and unvaccinated children worldwide. Despite several governmental and non-governmental agencies’ interventions, Nigeria has yet to ac…
Authors: Abisola Olaniyan, Chinwoke Isiguzo and Mary Hawk
Citation: BMC Public Health 2021 21:867
Content type: Research
Published on: 5 May 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 8 May 2021)

Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway
Since the human papillomavirus (HPV) vaccine was introduced in Norway in 2009, the vaccine uptake has increased. Whether this increase is similar regardless of the girls’ country background is unknown. We exam…
Authors: Randi Dalene Bjerke, Ida Laake, Berit Feiring, Geir Aamodt and Lill Trogstad
Citation: BMC Public Health 2021 21:854
Content type: Research article
Published on: 3 May 2021

Bulletin of the World Health Organization
Volume 99, Number 5, May 2021, 321-404
https://www.who.int/bulletin/volumes/99/5/en/

EDITORIALS
Consensus on disease control objectives in the context of COVID-19 vaccines
— Vageesh Jain & Sam Tweed
http://dx.doi.org/10.2471/BLT.20.283846

Bulletin of the World Health Organization
Volume 99, Number 5, May 2021, 321-404
https://www.who.int/bulletin/volumes/99/5/en/

RESEARCH
Gaps in health security related to wildlife and environment affecting pandemic prevention and preparedness, 2007–2020
— Catherine Machalaba, Marcela Uhart, Marie-Pierre Ryser-Degiorgis & William B Karesh
http://dx.doi.org/10.2471/BLT.20.272690

Conflict and Health
http://www.conflictandhealth.com/
[Accessed 8 May 2021]

Violence against healthcare in conflict: a systematic review of the literature and agenda for future research
Attacks on health care in armed conflict, including those on health workers, facilities, patients and transports, represent serious violations of human rights and international humanitarian law. Information ab…
Authors: Rohini J. Haar, Róisín Read, Larissa Fast, Karl Blanchet, Stephanie Rinaldi, Bertrand Taithe, Christina Wille and Leonard S. Rubenstein
Citation: Conflict and Health 2021 15:37
Content type: Review
Published on: 7 May 2021

EMBO Reports
Volume 22 Issue 5 5 May 2021
https://www.embopress.org/toc/14693178/current

Science & Society 5 May 2021 Open Access
Strength is in engagement: The rise of an online scientific community during the COVID‐19 pandemic
Christine E Cucinotta, Benjamin J E Martin, Melvin Noé González, Pravrutha Raman, Vladimir B Teif, Hanneke Vlaming
Many scientists, confined to home office by COVID‐19, have been gathering in online communities, which could become viable alternatives to physical meetings and conferences.

Expert Review of Vaccines
Vol 20 (3) 2021
https://www.tandfonline.com/toc/ierv20/current

Interview
COVID-19 and the rise of anti-science
Peter Hotez
Pages: 227-229
Published online: 22 Feb 2021

Expert Review of Vaccines
Vol 20 (3) 2021
https://www.tandfonline.com/toc/ierv20/current

Article
Latin American forum on immunization services during the COVID-19 pandemic
María L. Ávila-Agüero, Sebastián Ospina-Henao, María C. Pirez, Ángela Gentile, Soraya Araya, José Brea, Lourdes Mendoza & Luiza H. Falleiros-Arlant
Pages: 231-234
Published online: 20 Feb 2021

Humanitarian Exchange Magazine
Number 78, October 2020
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

Disability inclusion in humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange, co-edited with Sherin Alsheikh Ahmed from Islamic Relief Worldwide, is disability inclusion in humanitarian action. Persons with disabilities are not only disproportionately impacted by conflicts, disasters and other emergencies, but also face barriers to accessing humanitarian assistance. At the same time, global commitments and standards and the IASC Guidelines on the inclusion of persons with disabilities in humanitarian action all emphasise how persons with disabilities are also active agents of change. Disability and age-focused organisations have led on testing and demonstrating how inclusion can be done better. Yet despite this progress, challenges to effective inclusion remain.

As Kirstin Lange notes in the lead article, chief among these challenges is humanitarian agencies’ lack of engagement with organisations of persons with disabilities. Simione Bula, Elizabeth Morgan and Teresa Thomson look at disability inclusion in humanitarian response in the Pacific, and Kathy Al Jubeh and Alradi Abdalla argue for a ‘participation revolution’, building on learning from the gender movement. Tchaurea Fleury and Sulayman AbdulMumuni Ujah outline how the Bridge Article 11 training initiative is encouraging constructive exchange between humanitarian and disability actors. The lack of good, disaggregated data is highlighted by Sarah Collinson; Frances Hill, Jim Cranshaw and Carys Hughes emphasise the need for training resources in local languages and accessible formats; and Sophie Van Eetvelt and colleagues report on a review of the evidence on inclusion of people with disabilities and older people.

Rebecca Molyneux and co-authors analyse the findings of a review of a DFID programme in north-east Nigeria, while Carolin Funke highlights the importance of strategic partnerships between disability-focused organisations, drawing on her research in Cox’s Bazar. Sherin Alsheikh Ahmed describes Islamic Relief Worldwide’s approach to mainstreaming protection and inclusion, while Pauline Thivillier and Valentina Shafina outline IRC’s Client Responsive Programming. The edition ends with reflections by Mirela Turcanu and Yves Ngunzi Kahashi on CAFOD’s SADI approach.

JAMA
Online First

May 6, 2021
Original Investigation
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
Yoel Angel, MD, MBA; Avishay Spitzer, MD; Oryan Henig, MD; et al.
free access
JAMA. Published online May 6, 2021. doi:10.1001/jama.2021.7152
This cohort study estimates the association between Pfizer-BioNTech BNT162b2 vaccination and symptomatic and asymptomatic SARS-CoV-2 infections among health care workers more than 7 days after receipt of a second vaccine dose.

JAMA
Online First

Research Letter
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce
Li Tang, PhD; Diego R. Hijano, MD, MSc; Aditya H. Gaur, MD, MBBS; et al.
free access
JAMA. Published online May 6, 2021. doi:10.1001/jama.2021.6564
This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.
May 5, 2021

JAMA
May 4, 2021, Vol 325, No. 17, Pages 1703-1804
https://jamanetwork.com/journals/jama/currentissue

Research Letter
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky, MD, PhD; William A. Werbel, MD; Robin K. Avery, MD; et al.
free access
JAMA. Published online May 5, 2021. doi:10.1001/jama.2021.7489
This follow-up study measures the antibody response following the second dose of SARS-CoV-2 mRNA vaccine in recipients of solid organ transplants.

JAMA
May 4, 2021, Vol 325, No. 17, Pages 1703-1804
https://jamanetwork.com/journals/jama/currentissue

Viewpoint
Revised UNAIDS/WHO Ethical Guidance for HIV Prevention Trials
Rieke van der Graaf, PhD; Andreas Reis, MD, MSc; Peter Godfrey-Faussett, MBBS
free access
JAMA. 2021;325(17):1719-1720. doi:10.1001/jama.2021.0258
This Viewpoint summarizes updates to the UNAIDS/WHO document on ethical guidance for HIV prevention trials, emphasizing the importance of collaboration among trialists, sponsors, participants, and community members if the world is to reach a target of fewer than 200 000 new infections per year by 2030.

JAMA
May 4, 2021, Vol 325, No. 17, Pages 1703-1804
https://jamanetwork.com/journals/jama/currentissue

JAMA Live Highlights
Experts Discuss COVID-19—Variants and Vaccine Efficacy, Immunosuppressed Patients, and More
free access has active quiz has audio
JAMA. 2021;325(17):1711-1712. doi:10.1001/jama.2021.5938
JAMA Live Highlights features comments from livestream interviews with experts in clinical care, public health, and health policy on critical issues related to the COVID-19 pandemic. Comments have been edited for clarity.

JAMA Network
COVID-19 Update May 8, 2021

These articles on COVID-19 were published across the JAMA Network in the last week.

JAMA Pediatrics
May 2021, Vol 175, No. 5, Pages 449-544
https://jamanetwork.com/journals/jamapediatrics/currentissue

Original Investigation
Novel Variant Findings and Challenges Associated With the Clinical Integration of Genomic TestingAn Interim Report of the Genomic Medicine for Ill Neonates and Infants (GEMINI) Study
Jill L. Maron, MD, MPH; Stephen F. Kingsmore, MD; Kristen Wigby, MD; et al.
online only
JAMA Pediatr. 2021;175(5):e205906. doi:10.1001/jamapediatrics.2020.5906
This comparative effectiveness study reports interim variants and associated interpretations of an ongoing study comparing rapid whole-genomic sequencing with a novel targeted genomic platform.

The Lancet
May 08, 2021 Volume 397 Number 10286 p1683-1780
https://www.thelancet.com/journals/lancet/issue/current

Editorial
India’s COVID-19 emergency
… India must now pursue a two-pronged strategy. First, the botched vaccination campaign must be rationalised and implemented with all due speed. There are two immediate bottlenecks to overcome: increasing vaccine supply (some of which should come from abroad) and setting up a distribution campaign that can cover not just urban but also rural and poorer citizens, who constitute more than 65% of the population (over 800 million people) but face a desperate scarcity of public health and primary care facilities. The government must work with local and primary health-care centres that know their communities and create an equitable distribution system for the vaccine.
Second, India must reduce SARS-CoV-2 transmission as much as possible while the vaccine is rolled out. As cases continue to mount, the government must publish accurate data in a timely manner, and forthrightly explain to the public what is happening and what is needed to bend the epidemic curve, including the possibility of a new federal lockdown. Genome sequencing needs to be expanded to better track, understand, and control emerging and more transmissible SARS-CoV-2 variants. Local governments have begun taking disease-containment measures, but the federal government has an essential role in explaining to the public the necessity of masking, social distancing, halting mass gatherings, voluntary quarantine, and testing. Modi’s actions in attempting to stifle criticism and open discussion during the crisis are inexcusable.
The Institute for Health Metrics and Evaluation estimates that India will see a staggering 1 million deaths from COVID-19 by Aug 1. If that outcome were to happen, Modi’s Government would be responsible for presiding over a self-inflicted national catastrophe. India squandered its early successes in controlling COVID-19. Until April, the government’s COVID-19 taskforce had not met in months. The consequences of that decision are clear before us, and India must now restructure its response while the crisis rages. The success of that effort will depend on the government owning up to its mistakes, providing responsible leadership and transparency, and implementing a public health response that has science at its heart.

The Lancet
May 08, 2021 Volume 397 Number 10286 p1683-1780
https://www.thelancet.com/journals/lancet/issue/current

Articles
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
Victoria Jane Hall, et al and the SIREN Study Group

Nature
Volume 593 Issue 7857, 6 May 2021
https://www.nature.com/nature/volumes/593/issues/7857

Editorial | 04 May 2021
India, Brazil and the human cost of sidelining science
Governments that ignore or delay acting on scientific advice are missing out on a crucial opportunity to control the pandemic.
Last week, Brazil’s total death toll from COVID-19 passed 400,000. In India, the pandemic is taking around 3,500 lives every day and has prompted a global response, with offers of oxygen, ventilators, intensive-care beds and more. Although these two countries are thousands of miles apart, the crises in both are the result of political failings: their leaders have either failed or been slow to act on researchers’ advice. This has contributed to an unconscionable loss of life.

Brazil’s biggest failing is that its president, Jair Bolsonaro, has consistently mischaracterized COVID-19 as a “little flu” and has refused to follow scientific advice in setting policy, such as enforcing mask-wearing and limiting contact between people.

India’s leaders have not acted as decisively as was needed. They have, for example, allowed — and, in some cases, encouraged — large gatherings. Such a situation isn’t new. As we saw during the administration of former US president Donald Trump, ignoring evidence of the need to maintain physical distancing to combat COVID-19 has catastrophic consequences. The United States has recorded more than 570,000 deaths from the disease — still the world’s largest COVID-19 death toll in absolute terms.

As Nature reports in a World View article, India’s leaders became complacent after daily COVID-19 cases peaked at nearly 96,000 in September before slowly declining— to around 12,000 at the beginning of March. During this time, businesses reopened. Large gatherings followed, including protests against controversial new farm laws that brought thousands of farmers to New Delhi’s borders. Election rallies and religious gatherings also continued during March and April.

Nature
Volume 593 Issue 7857, 6 May 2021
https://www.nature.com/nature/volumes/593/issues/7857

Data difficulties
And India has other problems. One is that it’s not easy for scientists to access data for COVID-19 research. That, in turn, prevents them from providing accurate predictions and evidence-based advice to the government. Even in the absence of such data, researchers warned the government last September to be cautious about relaxing COVID-19 restrictions (Lancet 396, 867; 2020). And as late as the start of April, they warned that a second wave could see 100,000 COVID-19 cases a day by the end of the month.

On 29 April, more than 700 scientists wrote to Prime Minister Narendra Modi, asking for better access to data such as COVID-19 test results and clinical outcomes of patients in hospitals (see go.nature.com/3vc1svt), as well as a large-scale genome-surveillance programme to identify new variants (see go.nature.com/3vd7fak). The following day, Krishnaswamy Vijayraghavan, the government’s principal scientific adviser, acknowledged these concerns and clarified the ways in which researchers outside the government can access these data. This move has been welcomed by the letter’s signatories, but they have told Nature that some aspects of data access remain unclear.
A letter of protest shouldn’t have been necessary in the first place. By identifying themselves, the signatories took a risk: in the past, the Modi government has not reacted well to researchers organizing to question its policies. Two years ago, a letter from more than 100 economists and statisticians urging an end to political interference in official statistics was not well received by officials. The letter was written after the resignations of senior officials from India’s National Statistical Commission over what they saw as interference in the timing of the release of government data.

It’s never good when research communities have a difficult relationship with their national governments. But this can be fatal in the middle of a pandemic — when decisions need to be swift and evidence-based. By sidelining their scientists, the governments of Brazil and India have missed out on a crucial opportunity to reduce the loss of life.

During a pandemic, we all need our governments to succeed. However, it’s difficult to make good decisions quickly, more so with incomplete information — which is why health data need to be both accurate and accessible to researchers and clinicians. Denying or obscuring such access risks prolonging the pandemic.

Nature Reviews Drug Discovery
Volume 20 Issue 5, May 2021
https://www.nature.com/nrd/volumes/20/issues/5

Review Article | 01 March 2021
Strategies for delivering therapeutics across the blood–brain barrier
The blood–brain barrier is a perennial challenge for the delivery of therapeutics to the central nervous system. In their Review, Terstappen and colleagues discuss non-invasive approaches to brain delivery, particularly for biopharmaceuticals, some of which are now in clinical testing.
Georg C. Terstappen, Axel H. Meyer, Wandong Zhang

New England Journal of Medicine
May 6, 2021 Vol. 384 No. 18
http://www.nejm.org/toc/nejm/medical-journal

Perspective
A Half-Century of Progress in Health: The National Academy of Medicine at 50: Understanding and Mitigating Health Inequities — Past, Current, and Future Direction.
Risa J. Lavizzo-Mourey, M.D., M.B.A., Richard E. Besser, M.D., and David R. Williams, Ph.D., M.P.H.

New England Journal of Medicine
May 6, 2021 Vol. 384 No. 18
http://www.nejm.org/toc/nejm/medical-journal

Perspective Free Preview
Designing an Independent Public Health Agency
Jacqueline Salwa, B.A., and Christopher Robertson, J.D., Ph.D.
The Covid-19 pandemic has revealed the importance of having trustworthy and competent institutions to protect public health. Just as the United States has independent commissions in other important domains, it could benefit from an independent public health agency.

New England Journal of Medicine
May 6, 2021 Vol. 384 No. 18
http://www.nejm.org/toc/nejm/medical-journal

Perspective
Mass-Vaccination Sites — An Essential Innovation to Curb the Covid-19 Pandemic
Eric Goralnick, M.D., M.H.C.M., Christoph Kaufmann, Ph.D., M.B.A., and Atul A. Gawande, M.D., M.P.H.

PLoS One
http://www.plosone.org/
[Accessed 8 May 2021]

Chinese consumers’ willingness to get a COVID-19 vaccine and willingness to pay for it
Wen Qin, Erpeng Wang, Zhengyu Ni
Research Article | published 04 May 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0250112

PNAS – Proceedings of the National Academy of Sciences of the United States of America
April 27, 2021; vol. 118 no. 17
https://www.pnas.org/content/118/17

Commentaries
Understanding why we do what we do during a global pandemic
Sandro Galea
PNAS May 4, 2021 118 (18) e2104413118; https://doi.org/10.1073/pnas.2104413118

Public Health
Volume 193 Pages 1-156 (April 2021)
https://www.sciencedirect.com/journal/public-health/vol/193/suppl/C

Short communication Full text access
Vaccines for COVID-19: learning from ten phase II trials to inform clinical and public health vaccination programmes
Sunil S. Bhopal, Bayanne Olabi, Raj Bhopal

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 8 May 2021]

Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review
Coronavirus disease 2019 (COVID-19) has no confirmed specific treatments. However, there might be in vitro and early clinical data as well as evidence from severe acute respiratory syndrome and Middle Eastern …
Authors: Benjamin P. Geisler, Lara Zahabi, Adam Edward Lang, Naomi Eastwood, Elaine Tennant, Ljiljana Lukic, Elad Sharon, Hai-Hua Chuang, Chang-Berm Kang, Knakita Clayton-Johnson, Ahmed Aljaberi, Haining Yu, Chinh Bui, Tuan Le Mau, Wen-Cheng Li, Debbie Teodorescu…
Citation: Systematic Reviews 2021 10:143
Content type: Protocol
Published on: 7 May 2021

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 8 May 2021]

A systematic literature review of attitudes towards secondary use and sharing of health administrative and clinical trial data: a focus on consent
We aimed to synthesise data on issues related to stakeholder perceptions of consent for the use of secondary data. To better understand the current literature available, we conducted a systematic literature re…
Authors: Elizabeth Hutchings, Max Loomes, Phyllis Butow and Frances M. Boyle
Citation: Systematic Reviews 2021 10:132
Content type: Research
Published on: 4 May 2021

Travel Medicine and Infectious Diseases
Volume 41 May–June 2021
https://www.sciencedirect.com/journal/travel-medicine-and-infectious-disease/vol/41/suppl/C

Review article Open access
Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review
Jenny L. Schnyder, Hannah M. Garcia Garrido, Cornelis A. De Pijper, Joost G. Daams, … Martin P. Grobusch
Article 102007

Travel Medicine and Infectious Diseases
Volume 41 May–June 2021
https://www.sciencedirect.com/journal/travel-medicine-and-infectious-disease/vol/41/suppl/C

Research article Full text access
Sustainable border control policy in the COVID-19 pandemic: A math modeling study
Zhen Zhu, Enzo Weber, Till Strohsal, Duaa Serhan
Article 102044

Travel Medicine and Infectious Diseases
Volume 41 May–June 2021
https://www.sciencedirect.com/journal/travel-medicine-and-infectious-disease/vol/41/suppl/C

Research article Full text access
Cross-sectional analysis of COVID-19 vaccine intention, perceptions and hesitancy across Latin America and the Caribbean
Diego Urrunaga-Pastor, Guido Bendezu-Quispe, Percy Herrera-Añazco, Angela Uyen-Cateriano, … Vicente A. Benites-Zapata
Article 102059

Travel Medicine and Infectious Diseases
Volume 41 May–June 2021
https://www.sciencedirect.com/journal/travel-medicine-and-infectious-disease/vol/41/suppl/C

Short communication Full text access
COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic
Ranjit Sah, Asmita Priyadarshini Khatiwada, Sunil Shrestha, K.C. Bhuvan, … Alfonso J. Rodriguez-Morales
Article 102037

Tropical Medicine & International Health
Volume 26, Issue 5 Pages: i-iv, 503-608 May 2021
https://onlinelibrary.wiley.com/toc/13653156/current

Systematic Review Open Access
Behavioural interventions to address rational use of antibiotics in outpatient settings of low‐income and lower‐middle‐income countries
Mohit M. Nair, Raman Mahajan, Sakib Burza, Maurice P. Zeegers
Pages: 504-517
First Published: 16 January 2021

Vaccine
Volume 39, Issue 18 Pages 2479-2604 (28 April 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/18

Conference info Full text access
Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report
Sonia Pagliusi, Benoit Hayman, Stephen Jarrett
Pages 2479-2488

Vaccine
Volume 39, Issue 18 Pages 2479-2604 (28 April 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/18

Discussion Full text access
The development of COVID-19 vaccines in the United States: Why and how so fast?
Barbara J. Kuter, Paul A. Offit, Gregory A. Poland
Pages 2491-2495

Vaccine
Volume 39, Issue 18 Pages 2479-2604 (28 April 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/18

Discussion Full text access
COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER)
Sonali Kochhar, Eve Dubé, Janice Graham, Youngmee Jee, … Noni E. MacDonald
Pages 2504-2505

Vaccine
Volume 39, Issue 18 Pages 2479-2604 (28 April 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/18

Research article Open access
Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study
Antonio Giampiero Russo, Adriano Decarli, Maria Grazia Valsecchi
Pages 2517-2525

Vaccine
Volume 39, Issue 18 Pages 2479-2604 (28 April 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/18

Research article Abstract only
Modeling and presentation of vaccination coverage estimates using data from household surveys
Tracy Qi Dong, Jon Wakefield
Pages 2584-2594

Vaccine
Volume 39, Issue 18 Pages 2479-2604 (28 April 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/18

Research article Full text access
Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK
Daniel Allington, Siobhan McAndrew, Vivienne Louisa Moxham-Hall, Bobby Duffy
Pages 2595-2603

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

(Accessed 8 May 2021)
Open Access Article
Health System Barriers and Facilitators to Delivering Additional Vaccines through the National Immunisation Programme in China: A Qualitative Study of Provider and Service-User Perspectives
by Dan Gong, et al
Vaccines 2021, 9(5), 476; https://doi.org/10.3390/vaccines9050476 (registering DOI) – 08 May 2021
Abstract
In China, there are two categories of vaccines available from the Chinese Center for Disease Control and associated public health agencies. Extended Program of Immunization (EPI) vaccines are government-funded and non-EPI vaccines are voluntary and paid for out-of-pocket. The government plans to transition […]

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

Open Access Article
A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community
by Magdalena Grochowska et al
Vaccines 2021, 9(5), 475; https://doi.org/10.3390/vaccines9050475 (registering DOI) – 08 May 2021
Abstract
Despite research conducted worldwide, there is no treatment specifically targeting SARS-CoV-2 infection with efficacy proven by randomized controlled trials. A chance for a breakthrough is vaccinating most of the global population. Public opinion surveys on vaccine hesitancy prompted our team to investigate Polish […

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

Open Access Article
Attitudes towards COVID-19 Vaccination among Hospital Staff—Understanding What Matters to Hesitant People
by Anne Spinewine et al
Vaccines 2021, 9(5), 469; https://doi.org/10.3390/vaccines9050469 – 06 May 2021
Abstract
Hospital staff are a priority target group in the European COVID-19 vaccination strategy. Measuring the extent of COVID-19 vaccination hesitancy and understanding the reasons behind it are essential to be able to tailor effective communication campaigns. Using the Health Belief Model (HBM) as […]

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

Open Access Article
Hesitancy of Arab Healthcare Workers towards COVID-19 Vaccination: A Large-Scale Multinational Study
by Eyad Qunaibi et al
Vaccines 2021, 9(5), 446; https://doi.org/10.3390/vaccines9050446 – 02 May 2021
Abstract
Background: Health care workers (HCWs) are at increased risk of acquiring and transmitting COVID-19 infection. Moreover, they present role models for communities with regards to attitudes towards COVID-19 vaccination. Hence, hesitancy of HCWs towards vaccination can crucially affect the efforts aiming to contain […]